Clinical Trial Update: Fuzheng Yiliu-1010 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Fuzheng Yiliu-1010 in colorectal cancer (Stage II/III). Status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Fuzheng Yiliu-1010

Snippet

Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine | Conditions: Colorectal Cancer Stage II and III | Phase 2 | Status: UNKNOWN